Cart (0)
 
 

Home

ASX Market Wrap for Wednesday 23th October does another line effect size of the image
Featured

ASX Market Wrap for Wednesday 23th October does another line effect size of the image

December 5, 2017
The shifting face of Corporate Social Responsibility
Featured

The shifting face of Corporate Social Responsibility

March 5, 2024
Corporate Social Responsibility: a multidimensional challenge
Featured

Corporate Social Responsibility: a multidimensional challenge

March 5, 2024

Submit Your Email now, and get
Our Latest update

NEWS

should be in news top section as I am newf
News

should be in news top section as I am newf

November 5, 2024
AI is almost back
ArticlesDiaryeventsFloats & ListingsFundraisingNews

AI is almost back

September 5, 2024
The Oxygen Project:
News

The Oxygen Project:

September 5, 2024
testing news
News

testing news

September 5, 2024
company new test
ArticlesNews

company new test

September 5, 2024
Tasmea edited IPO
FundraisingNews

Tasmea edited IPO

April 5, 2024

FUNDRAISING


N/A
this appear on home page and in FR table ?



N/A
TEST9999



test
Andrew and Shelley
IPO


Maintenance, engineering and sustaining capital service provider
Tasmea Limited ASX Listing
IPO


Oil and Gas Exploration
D3 Energy Limited



BlinkLab was incorporated on 17 August 2021 for the purpose of accelerating the development and commercialisation of intellectual property developed at Princeton University relating to smartphone-neurobehavioral testing (Licenced IP). BlinkLab has the exclusive worldwide licence to commercialise the Licenced IP and has developed a smartphone-based application with an e-platform that serves as a medical device to perform neurometric tests to aid in the diagnosis of autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), schizophrenia and other neurodevelopmental conditions (BlinkLab Device). The tests include, but are not limited to, eyeblink conditioning (EBC), prepulse inhibition of acoustic startle (PPI) and habituation of eye blink response which serve as biomarkers for neurological and psychiatric disorders (BlinkLab Tests). The results from the BlinkLab Tests are recorded by smartphone and uploaded to BlinkLab’s confidential and secure online platform where the data is analysed using machine learning (ML). Upon admission, the primary focus of BlinkLab will be to complete the necessary regulatory clinical studies and obtain the necessary regulatory approvals (that being FDA approval in the US and CE Mark in Europe) to bring the BlinkLab Device to market initially as a diagnostic tool for ASD.
Blinklab Limited
IPO


1111
TestS
NSX


N/A
this is a t test

ARTICLES

Does US Tax Overhaul Violate Global Trade Rules?
Articles

Does US Tax Overhaul Violate Global Trade Rules?

December 5, 2019
New Daring Street Style Trends Started by Gorgeous
Articles

New Daring Street Style Trends Started by Gorgeous

December 5, 2019
NPO Show Will Return for Spring 2020 Premiere
Articles

NPO Show Will Return for Spring 2020 Premiere

December 5, 2019
AI is almost back
ArticlesDiaryeventsFloats & ListingsFundraisingNews

AI is almost back

September 5, 2024
Article top new test
Articles

Article top new test

September 5, 2024
company new test
ArticlesNews

company new test

September 5, 2024
edit makes master ?The Oxygen Project – A global view
Articles

edit makes master ?The Oxygen Project – A global view

May 5, 2024
ABB’s legal action against Superloops
Articles

ABB’s legal action against Superloops

September 5, 2024

AI Membership

AI Membership

$99.00
AI

Join Now

Home Loans and Finance

$0.00
Included in Membership

Join Now

Hotel Accomodation

$0.00
Included in Membership

Join Now

Car Hire

$0.00
Included in Membership

Join Now

Share trading

$0.00
Included in Membership

Join Now